INS and obesity disorder: Obesity associated with metabolic syndrome results in increased levels of insulin and insulin-like growth factor (IGF), which mediate endometrial cancer growth; in turn, hyperinsulinemia is associated with lower levels of sex hormone-binding globulin, which increases the bioavailability of circulating estrogens.